2 Projects | 1 Researchers | $2,740,209 Invested
2021
NeuroVision Imaging, Inc.
Leyla Anderson, MD, PhD, D(ABMLI)
Validation and commercialization of a novel blood-based, ultra-multiplex Laboratory Developed Test (LDT) for the prediction of cerebral amyloid status before clinical onset of dementia.
2020
NeuroVision Imaging, Inc.
Validation of blood based biomarkers for the detection of brain amyloid accumulation before clinical onset of dementia.